Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, Russia.
Henan International Joint Laboratory of Children's Infectious Diseases, Henan Children's Hospital, Children's Hospital, Zhengzhou University, Zhengzhou Children's Hospital, Zhengzhou, China.
BMC Infect Dis. 2023 Jun 23;23(1):426. doi: 10.1186/s12879-023-08413-7.
. The Mycobacterium tuberculosis Beijing genotype is globally spread lineage with important medical properties that however vary among its subtypes. M. tuberculosis Beijing 14717-15-cluster was recently discovered as both multidrug-resistant, hypervirulent, and highly-lethal strain circulating in the Far Eastern region of Russia. Here, we aimed to analyze its pathogenomic features and phylogeographic pattern.
. The study collection included M. tuberculosis DNA collected between 1996 and 2020 in different world regions. The bacterial DNA was subjected to genotyping and whole genome sequencing followed by bioinformatics and phylogenetic analysis. The PCR-based assay to detect specific SNPs of the Beijing 14717-15-cluster was developed and used for its screening in the global collections. Phylogenomic and phylogeographic analysis confirmed endemic prevalence of the Beijing 14717-15-cluster in the Asian part of Russia, and distant common ancestor with isolates from Korea (> 115 SNPs). The Beijing 14717-15-cluster isolates had two common resistance mutations RpsL Lys88Arg and KatG Ser315Thr and belonged to spoligotype SIT269. The Russian isolates of this cluster were from the Asian Russia while 4 isolates were from the Netherlands and Spain. The cluster-specific SNPs that significantly affect the protein function were identified in silico in genes within different categories (lipid metabolism, regulatory proteins, intermediary metabolism and respiration, PE/PPE, cell wall and cell processes).
. We developed a simple method based on real-time PCR to detect clinically significant MDR and hypervirulent Beijing 14717-15-cluster. Most of the identified cluster-specific mutations were previously unreported and could potentially be associated with increased pathogenic properties of this hypervirulent M. tuberculosis strain. Further experimental study to assess the pathobiological role of these mutations is warranted.
结核分枝杆菌北京基因型是一种在全球范围内广泛传播的谱系,具有重要的医学特性,但在其亚型之间有所不同。最近发现结核分枝杆菌北京 14717-15 聚类是一种多药耐药、高毒力和高致死率的菌株,在俄罗斯远东地区流行。本研究旨在分析其病原体基因组特征和系统发育模式。
研究收集了 1996 年至 2020 年在不同世界区域采集的结核分枝杆菌 DNA。对细菌 DNA 进行基因分型和全基因组测序,然后进行生物信息学和系统发育分析。开发了一种基于 PCR 的检测北京 14717-15 聚类特异性 SNPs 的方法,并用于全球样本的筛查。系统基因组学和系统发育分析证实了北京 14717-15 聚类在俄罗斯亚洲部分的地方性流行,与韩国分离株具有遥远的共同祖先(>115 个 SNPs)。北京 14717-15 聚类分离株有两个常见的耐药突变 RpsL Lys88Arg 和 KatG Ser315Thr,属于 spoligotype SIT269。该聚类的俄罗斯分离株来自亚洲的俄罗斯,而 4 株分离株来自荷兰和西班牙。通过计算机在不同类别(脂质代谢、调节蛋白、中间代谢和呼吸、PE/PPE、细胞壁和细胞过程)的基因中鉴定出对蛋白质功能有显著影响的聚类特异性 SNPs。
我们开发了一种基于实时 PCR 的简单方法来检测具有临床意义的 MDR 和高毒力北京 14717-15 聚类。大多数鉴定出的聚类特异性突变以前未报道过,可能与这种高毒力结核分枝杆菌菌株的致病性增加有关。需要进一步的实验研究来评估这些突变的病理生物学作用。